ZAPI Product Coordinator Boehringer Ingelheim Santé Animale - France
Topic: Emerging threats prediction and prevention - a pre-emptive approach Session: VM3 - Challenges of responding to new disease outbreaks When: 6 October | 8:30 – 11:00 BST (GMT+1)
Chief Executive Veterinary Medicines Directorate - United Kingdom Topic: Global regulatory convergence Session: VM5 - Opportunities of global regulatory convergence When: 6 October | 16:45 – 18:15 BST (GMT+1)
Head of Veterinary Medicines Division European Medicines Agency (EMA) Topic: EMA/EU as global leader/agency Session: VM5 - Opportunities of global regulatory convergence When: 6 October | 16:45 – 18:15 BST (GMT+1)
Technical Director HealthforAnimals and AnimalhealthEurope - Belgium
Topic: Challenges for industry Session: VM5 - Opportunities of global regulatory convergence When: 6 October | 16:45 – 18:15 BST (GMT+1)
Head of Veterinary Medicinal Products Federal Office of Consumer Protection and Food Safety (BVL) - Germany
Veterinary Pharmcovigilance Expert Federal Agency for Medicines and Health Products (FAMHP) - Belgium
Topic: PhV and signal detection/management Session: VM4 - Practical implementation of the new Veterinary Regulation When: 6 October | 12:00 – 13:30 BST (GMT+1)
CMDv Member Austrian Federal Office for Safety in Healthcare (BASG) - Austria
Topic: Variations Session: VM4 - Practical implementation of the new Veterinary Regulation When: 6 October | 12:00 – 13:30 BST (GMT+1)
CEO Central Vet Pharma Consultancy - Denmark
Topic: Annex 2 / novel therapies / biologicals update Session: VM2 - Regulation versus innovation: Do new products need rules? When: 5 October | 14:15 – 15:45 BST (GMT+1)
Principal Consultant, Global Regulatory New Product Development Elanco Animal Health - Switzerland
Topic: Authorisations in limited markets, EU and US Session: VM2 - Regulation versus innovation: Do new products need new rules? When: 5 October | 14:15 – 15:45 BST (GMT+1)
Head of Veterinary Division and CMDv Member Federal Agency for Medicines and Health Products (FAMHP) - Belgium Topic: SmPC harmonisation Session: VM2 - Regulation versus innovation: Do new products need new rules? When: 5 October | 14:15 – 15:45 BST (GMT+1)
Head of Technical and Regulatory Affairs National Office of Animal Health (NOAH) - UK Topic: Industry and regulatory adaptation to deal with disease threats and other extraordinary scenarios Session: VM3 - Challenges of responding to new disease outbreaks When: 6 October | 8:30 – 11:00 BST (GMT+1)
Director, Regulatory Affairs Zoetis - UK
Topic: Regulatory Science Strategy; is it suitable for an innovative industry? Session: VM1: Parallel strategic developments in the EU regulatory network When: 5 October | 10:45 – 12:15 BST (GMT+1)
Federal Agency for Medicines and Health Products (FAMHP) - Belgium
Topic: Authorisations in limited markets and exceptional circumstances, EU and US Session: VM2: Regulation versus innovation: do new products need new rules? When: 5 October | 14:15 – 15:45 BST (GMT+1)
Director, Global Regulatory Affairs - Biologicals / Immunologicals Intervet International BV (aka MSD Animal Health) - the Netherlands Topic: Responding to a future significant animal health disease outbreak – is the EU regulatory landscape prepared? Session: VM3: Challenges of responding to new disease outbreaks When: 6 October | 8:30 – 11:00 BST (GMT+1)
Head of Regulatory Affairs, North America Coalition for Epidemic Preparedness Innovations (CEPI) - USA
Topic: Epidemic preparedness Session: Annual Lecture When: 29 September | 14:30 – 15:30 BST (GMT+1)
Public Affairs Expert France
Session Leader and Chair: VM4 - Practical implementation of the New Veterinary Regulation
When: 6 October | 12:00 – 13:30 BST (GMT+1)
Session Leader: VM1 - Parallel strategic development in the EU regulatory network When: 5 October | 10:45 – 12:15 BST (GMT+1)
Head of Biologicals and Emerging Therapies, Veterinary Division European Medicines Agency (EMA) Session Chair: VM3 - Challenges of responding to new disease outbreaks When: 6 October | 8:30 – 11:00 BST (GMT+1)
Session Leader and Chair: VM5 - Opportunities of global regulatory convergence When: 6 October | 16:45 – 18:15 BST (GMT+1)
Session Leader and Chair: VM2 - Regulation versus innovation: Do new products need new rules? When: 5 October | 14:15 – 15:45 BST (GMT+1)
Federal Agency for Medicines and Health Products (FAMHP) Belgium Session Chair: VM1 - Parallel strategic development in the EU regulatory network When: 5 October | 10:45 – 12:15 BST (GMT+1)
Manager, Regulatory Affairs Triveritas - UK